Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ingram Micro Holding Corp | INGM | Nov 22, 2024 | 22.00 | 0.00 |
Ingredion | INGR | Nov 22, 2024 | 146.47 | +1.46 |
Inhibikase Therapeutics | IKT | Nov 22, 2024 | 2.31 | +14.93 |
Inhibrx Biosciences | INBX | Nov 22, 2024 | 14.08 | +0.72 |
InMed Pharmaceuticals | INM | Nov 22, 2024 | 4.66 | +0.22 |
InMode | INMD | Nov 22, 2024 | 19.02 | +2.89 |
INmune Bio | INMB | Nov 22, 2024 | 4.87 | +2.31 |
Innate Pharma ADR | IPHA | Nov 22, 2024 | 1.63 | -4.12 |
Inno Holdings | INHD | Nov 22, 2024 | 4.96 | -1.98 |
Innodata | INOD | Nov 22, 2024 | 44.77 | -3.16 |
Innospec | IOSP | Nov 22, 2024 | 119.75 | +1.19 |
InnovAge | INNV | Nov 22, 2024 | 4.89 | +5.62 |
Innovate | VATE | Nov 22, 2024 | 5.99 | +24.27 |
Innovation Beverage Group | IBG | Nov 22, 2024 | 1.11 | 0.00 |
Innovative Eyewear | LUCY | Nov 22, 2024 | 6.56 | -2.38 |
Innovative Industrial Properties | IIPR | Nov 22, 2024 | 107.12 | +1.28 |
Innovative Industrial Properties A Pref | IIPR-A | Nov 22, 2024 | 26.34 | -0.29 |
Innovative Solutions and Support | ISSC | Nov 22, 2024 | 7.70 | +3.08 |
Innovex International | INVX | Nov 22, 2024 | 17.58 | 0.00 |
Innovid | CTV | Nov 22, 2024 | 3.05 | +1.33 |
Innoviva | INVA | Nov 22, 2024 | 19.15 | +0.47 |
Innoviz Technologies | INVZ | Nov 22, 2024 | 0.53 | +0.47 |
InnSuites Hospitality | IHT | Nov 22, 2024 | 2.13 | +4.67 |
Innventure | INV | Nov 22, 2024 | 11.13 | 0.00 |
Inogen | INGN | Nov 22, 2024 | 9.38 | +1.85 |
Inotiv | NOTV | Nov 22, 2024 | 3.59 | +5.28 |
Inovio Pharmaceuticals | INO | Nov 22, 2024 | 4.07 | +0.25 |
Inozyme Pharma | INZY | Nov 22, 2024 | 2.81 | +4.46 |
Inpixon | XTIA | Nov 22, 2024 | 0.05 | -5.11 |
InPoint Commercial Real Estate Pref A | ICR-A | Nov 22, 2024 | 20.83 | +0.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.